List of bibliographic references indexed by Suède
Number of relevant bibliographic references: 9.
| Ident. | Authors (with country if any) | Title |
|---|
| 000818 (2019) |
C. Turesson [Suède] ; O. Börjesson [Suède] ; K. Larsson [Suède] ; A J Mohammad [Suède] ; A. Knight [Suède] | Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis. |
| 000954 (2019) |
Diederik De Cock [Belgique] ; Patrick Verschueren [Belgique] | Primus inter pares: the choice of biologic drugs in rheumatoid arthritis. |
| 000E52 (2019) |
Thomas Frisell [Suède] ; Johan Askling [Suède] | Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply. |
| 000E53 (2019) |
Thomas Frisell [Suède] ; Johan Askling [Suède] | Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply. |
| 000E54 (2019) |
Hasan Sat ; Gülce Ecem Can [Turquie] ; Reyhan Bilici Salman ; Asl Han Avano Lu Güler ; Hazan Karadeniz ; Abdurrahman Tufan | Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register. |
| 000E55 (2019) |
Andrew N B. Weil [Royaume-Uni] | Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from a nationwide Swedish register. |
| 001264 (2018) |
Thomas Frisell [Suède] ; Eva Baecklund [Suède] ; Karin Bengtsson [Suède] ; Daniela Di Giuseppe [Suède] ; Helena Forsblad-D'Elia [Suède] ; Johan Askling [Suède] | Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics. |
| 001342 (2018) |
Anne Holbrook | In patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms. |
| 001838 (2017) |
Tanja Schj Dt J Rgensen [Danemark] ; Carl Turesson [Suède] ; Meliha Kapetanovic [Suède] ; Martin Englund [Suède] ; Aleksandra Turkiewicz [Suède] ; Robin Christensen [Danemark] ; Henning Bliddal [Danemark] ; Pierre Geborek [Suède] ; Lars Erik Kristensen [Danemark] | EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Suède"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i \
-Sk "Suède" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdFr.i
|clé= Suède
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
